Shadow, I have been with SCRC for well over a year now. I believe it will be successful. What am I supposed to post on this board, sell now!? No way. If I am perceived as a pom-pom carrier or cheerleader, so be it. Now investors who aren't happy with the stock can post what they want and that's okay. But anyone posting anything positive is now being perceived as liars or promoters. Most of the posters who have questions they don't even have the guts to call the CEO directly and seek responses. They ask the questions here on the board and expect answers. What I know is what I read in the PRs. Yes, there are always rumors flying around but what I post is based on my own DD and the PRs. I have done a tremendous amount of DD on compound pharmacy and where we are now in terms of generating revenues is just the beginning. I just visited a pain specialist in Baltimore today with one of my Reps and this doctor told us several of his colleagues are now looking at topical compunding creams as the answer to moving away from prescribing addictive narcotics to relieve chronic pain. Is SCRC in a growing market, you bet it is. I happen to believe in Mr. Schneiderman and realize he is making all the right decisions and will eventually respond to all our questions when he can.
Shadow, I have been with SCRC for well over a year now. I
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
MIT45 Takes a Stand Against Synthetic Kratom Practices
MIT45's Firm Stance on Kratom Safety MIT45, a leading name in the kratom market, stands firmly against the irresponsible and hazardous practice of producing synthetic 7-hydroxymitragynine (7-OH). This commitment to consumer protection is especially important as products claiming to contain kratom often do not meet safety standards and could threaten public health. By...
Continue Reading
Canso Credit Income Fund Announces Special Distributions This Year
Canso Credit Income Fund's Special Distributions Explained Lysander Funds Limited is excited to share important updates regarding the Canso Credit Income Fund (TSX: PBY). This announcement pertains to the special distributions being issued for various classes of units within the Fund for the tax year ending 2024. Understanding these distributions is vital for both...
Continue Reading
Blue Cross and Blue Shield of Texas Expands Community Support with Grants
Blue Cross and Blue Shield of Texas Awards Community Grants Blue Cross and Blue Shield of Texas (BCBSTX) has announced an impressive investment of $2 million in community-based grants. This funding will go to 84 organizations across the state, all focused on enhancing accessibility to health services and tackling social determinants that significantly impact the...
Continue Reading
Dr. Soroush Baghdadi Enhances Pediatric Care at LuskinOIC
Welcoming Dr. Soroush Baghdadi to Luskin Orthopaedic Institute The Luskin Orthopaedic Institute for Children takes great pride in announcing the addition of Dr. Soroush Baghdadi to its distinguished team of pediatric orthopaedic specialists. With an impressive background enriched by global experience and a passion for pediatric care, Dr. Baghdadi brings a promising vision...
Continue Reading
Fractyl Health to Share Q3 Results and Business Insights Soon
Fractyl Health to Discuss Upcoming Financial Insights In Burlington, Massachusetts, Fractyl Health, Inc. (Nasdaq: GUTS) is preparing to unveil its financial results for the third quarter of 2025 along with business updates. This event is scheduled for a Wednesday at 4:30 PM ET, where key insights into the company’s progress will be shared. Accessing the Live Event...
Continue Reading